US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist
  • 250.000
  • -6.450-2.52%
Close Feb 18 16:00 ET
  • 251.000
  • +1.000+0.40%
Post 17:21 ET
32.36BMarket Cap-114.68P/E (TTM)

Alnylam Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-107.98%-8.31M
-217.71%-94.66M
-87.84%43.71M
310.49%124.16M
51.03%-81.52M
119.24%104.16M
77.42%-29.8M
411.76%359.41M
51.97%-58.99M
2.76%-166.48M
Net income from continuing operations
36.82%-278.16M
39.24%-83.76M
-175.51%-111.57M
93.88%-16.89M
62.13%-65.94M
61.08%-440.24M
33.55%-137.87M
136.40%147.75M
0.50%-276.02M
27.56%-174.1M
Operating gains losses
61.01%173.79M
215.37%70.44M
-21.26%37.84M
97.84%57.01M
-2.63%8.51M
-47.23%107.94M
30.71%22.34M
-56.12%48.05M
-12.70%28.82M
-80.56%8.74M
Depreciation and amortization
4.84%56.67M
-8.11%-20.55M
14.90%27.04M
5.31%24.69M
-2.27%25.49M
21.56%54.05M
-17.33%-19M
13.96%23.53M
15.86%23.45M
31.86%26.08M
Deferred tax
-14,873.63%-106.76M
----
----
----
----
50.24%-713K
----
----
----
----
Other non cash items
-15.39%88.15M
180.65%28.54M
-72.60%13.87M
-20.64%19.36M
38.83%26.38M
0.15%104.18M
167.96%10.17M
82.75%50.61M
-34.83%24.4M
-45.87%19M
Change In working capital
-473.87%-214.08M
-239.25%-74.21M
20.38%30.73M
-176.35%-49.3M
-40.82%-121.3M
651.65%57.26M
80.68%53.29M
448.47%25.53M
93.17%64.58M
-43.65%-86.14M
-Change in receivables
1.58%-86.55M
-1,638.07%-59.51M
65.65%-37.09M
424.58%9.64M
-97.86%410K
-92.86%-87.94M
107.26%3.87M
-181.06%-107.99M
-146.41%-2.97M
-51.75%19.15M
-Change in inventory
-26.01%13.59M
-92.92%849K
23.57%5.93M
242.27%6.79M
105.46%22K
153.81%18.37M
163.18%11.99M
160.82%4.8M
121.58%1.99M
-120.92%-403K
-Change in prepaid assets
135.76%3.23M
8.05%25.28M
-149.46%-8.28M
321.31%61.69M
-6,010.28%-75.46M
76.55%-9.03M
169.34%23.4M
-183.68%-3.32M
-30.82%-27.87M
95.86%-1.24M
-Change in payables and accrued expense
12.68%91.09M
-60.62%-62.11M
-29.60%83.6M
-10.00%74.47M
94.07%-4.87M
-57.85%80.84M
-137.68%-38.67M
70.25%118.74M
21.42%82.74M
-68.20%-81.98M
-Change in other current liabilities
----
----
-25.78%-14.05M
0.63%-10.95M
-0.10%-12.84M
----
----
-8.59%-11.17M
-2.40%-11.02M
-20.19%-12.83M
-Change in other working capital
-527.91%-235.45M
-193.64%-16.56M
-97.45%624K
-979.27%-190.94M
-222.75%-28.56M
183.48%55.02M
142.85%17.69M
296.29%24.47M
13,644.30%21.72M
28.19%-8.85M
Cash from discontinued investing activities
Operating cash flow
-107.98%-8.31M
-217.71%-94.66M
-87.84%43.71M
310.49%124.16M
51.03%-81.52M
119.24%104.16M
77.42%-29.8M
411.76%359.41M
51.97%-58.99M
2.76%-166.48M
Investing cash flow
Cash flow from continuing investing activities
65.26%-116.84M
78.01%-52.91M
-181.03%-30.25M
489.53%33.94M
11.28%-67.62M
-298.61%-336.35M
-72.01%-240.66M
-103.43%-10.76M
-106.10%-8.71M
48.30%-76.22M
Net PPE purchase and sale
44.90%-34.28M
40.60%-9.09M
75.47%-4.19M
49.63%-8.02M
6.61%-12.97M
13.67%-62.21M
29.24%-15.31M
-3.53%-17.09M
0.85%-15.92M
22.22%-13.89M
Net investment purchase and sale
76.55%-63.25M
80.61%-43.7M
-163.70%-6.86M
482.26%41.96M
12.32%-54.65M
-205.93%-269.7M
-89.91%-225.35M
-96.79%10.77M
-95.69%7.21M
51.87%-62.33M
Net other investing changes
-335.26%-19.32M
---117K
----
----
----
66.36%-4.44M
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
65.26%-116.84M
78.01%-52.91M
-181.03%-30.25M
489.53%33.94M
11.28%-67.62M
-298.61%-336.35M
-72.01%-240.66M
-103.43%-10.76M
-106.10%-8.71M
48.30%-76.22M
Financing cash flow
Cash flow from continuing financing activities
70.89%294.16M
-20.98%31M
210.08%102.76M
146.27%131.5M
-37.65%28.91M
-59.57%172.13M
-38.16%39.23M
-88.84%33.14M
76.00%53.39M
32.66%46.37M
Net issuance payments of debt
--0
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
105.44%302.95M
17.43%36.28M
335.54%108.04M
168.81%132.78M
-38.97%25.86M
-43.14%147.46M
-45.53%30.89M
-83.79%24.81M
119.50%49.39M
56.22%42.37M
Net other financing activities
-135.64%-8.79M
-163.37%-5.28M
-163.37%-5.28M
-132.05%-1.28M
-23.70%3.05M
128.16%24.67M
107.50%8.33M
6.38%8.33M
-48.94%4M
-48.93%4M
Cash from discontinued financing activities
Financing cash flow
70.89%294.16M
-20.98%31M
210.08%102.76M
146.27%131.5M
-37.65%28.91M
-59.57%172.13M
-38.16%39.23M
-88.84%33.14M
76.00%53.39M
32.66%46.37M
Net cash flow
Beginning cash position
-6.18%814.88M
6.50%1.1B
47.16%971.19M
1.53%684.72M
-6.18%814.88M
5.64%868.56M
-3.74%1.04B
14.24%659.98M
25.76%674.41M
5.64%868.56M
Current changes in cash
381.38%169.01M
49.58%-116.58M
-69.56%116.21M
2,124.43%289.59M
38.76%-120.22M
-211.57%-60.06M
-10.92%-231.22M
-22.97%381.79M
-128.43%-14.31M
30.79%-196.32M
Effect of exchange rate changes
-338.44%-15.24M
-258.49%-17.27M
330.36%15.09M
-2,300.00%-3.12M
-556.85%-9.94M
186.02%6.39M
573.07%10.9M
-423.72%-6.55M
98.53%-130K
197.23%2.18M
End cash Position
18.87%968.65M
18.87%968.65M
6.50%1.1B
47.16%971.19M
1.53%684.72M
-6.18%814.88M
-6.18%814.88M
-3.74%1.04B
14.24%659.98M
25.76%674.41M
Free cash flow
-201.54%-42.59M
-130.04%-103.76M
-88.46%39.52M
255.05%116.14M
47.61%-94.49M
106.84%41.95M
70.64%-45.1M
359.74%342.32M
46.06%-74.91M
4.59%-180.37M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -107.98%-8.31M-217.71%-94.66M-87.84%43.71M310.49%124.16M51.03%-81.52M119.24%104.16M77.42%-29.8M411.76%359.41M51.97%-58.99M2.76%-166.48M
Net income from continuing operations 36.82%-278.16M39.24%-83.76M-175.51%-111.57M93.88%-16.89M62.13%-65.94M61.08%-440.24M33.55%-137.87M136.40%147.75M0.50%-276.02M27.56%-174.1M
Operating gains losses 61.01%173.79M215.37%70.44M-21.26%37.84M97.84%57.01M-2.63%8.51M-47.23%107.94M30.71%22.34M-56.12%48.05M-12.70%28.82M-80.56%8.74M
Depreciation and amortization 4.84%56.67M-8.11%-20.55M14.90%27.04M5.31%24.69M-2.27%25.49M21.56%54.05M-17.33%-19M13.96%23.53M15.86%23.45M31.86%26.08M
Deferred tax -14,873.63%-106.76M----------------50.24%-713K----------------
Other non cash items -15.39%88.15M180.65%28.54M-72.60%13.87M-20.64%19.36M38.83%26.38M0.15%104.18M167.96%10.17M82.75%50.61M-34.83%24.4M-45.87%19M
Change In working capital -473.87%-214.08M-239.25%-74.21M20.38%30.73M-176.35%-49.3M-40.82%-121.3M651.65%57.26M80.68%53.29M448.47%25.53M93.17%64.58M-43.65%-86.14M
-Change in receivables 1.58%-86.55M-1,638.07%-59.51M65.65%-37.09M424.58%9.64M-97.86%410K-92.86%-87.94M107.26%3.87M-181.06%-107.99M-146.41%-2.97M-51.75%19.15M
-Change in inventory -26.01%13.59M-92.92%849K23.57%5.93M242.27%6.79M105.46%22K153.81%18.37M163.18%11.99M160.82%4.8M121.58%1.99M-120.92%-403K
-Change in prepaid assets 135.76%3.23M8.05%25.28M-149.46%-8.28M321.31%61.69M-6,010.28%-75.46M76.55%-9.03M169.34%23.4M-183.68%-3.32M-30.82%-27.87M95.86%-1.24M
-Change in payables and accrued expense 12.68%91.09M-60.62%-62.11M-29.60%83.6M-10.00%74.47M94.07%-4.87M-57.85%80.84M-137.68%-38.67M70.25%118.74M21.42%82.74M-68.20%-81.98M
-Change in other current liabilities ---------25.78%-14.05M0.63%-10.95M-0.10%-12.84M---------8.59%-11.17M-2.40%-11.02M-20.19%-12.83M
-Change in other working capital -527.91%-235.45M-193.64%-16.56M-97.45%624K-979.27%-190.94M-222.75%-28.56M183.48%55.02M142.85%17.69M296.29%24.47M13,644.30%21.72M28.19%-8.85M
Cash from discontinued investing activities
Operating cash flow -107.98%-8.31M-217.71%-94.66M-87.84%43.71M310.49%124.16M51.03%-81.52M119.24%104.16M77.42%-29.8M411.76%359.41M51.97%-58.99M2.76%-166.48M
Investing cash flow
Cash flow from continuing investing activities 65.26%-116.84M78.01%-52.91M-181.03%-30.25M489.53%33.94M11.28%-67.62M-298.61%-336.35M-72.01%-240.66M-103.43%-10.76M-106.10%-8.71M48.30%-76.22M
Net PPE purchase and sale 44.90%-34.28M40.60%-9.09M75.47%-4.19M49.63%-8.02M6.61%-12.97M13.67%-62.21M29.24%-15.31M-3.53%-17.09M0.85%-15.92M22.22%-13.89M
Net investment purchase and sale 76.55%-63.25M80.61%-43.7M-163.70%-6.86M482.26%41.96M12.32%-54.65M-205.93%-269.7M-89.91%-225.35M-96.79%10.77M-95.69%7.21M51.87%-62.33M
Net other investing changes -335.26%-19.32M---117K------------66.36%-4.44M--0------------
Cash from discontinued investing activities
Investing cash flow 65.26%-116.84M78.01%-52.91M-181.03%-30.25M489.53%33.94M11.28%-67.62M-298.61%-336.35M-72.01%-240.66M-103.43%-10.76M-106.10%-8.71M48.30%-76.22M
Financing cash flow
Cash flow from continuing financing activities 70.89%294.16M-20.98%31M210.08%102.76M146.27%131.5M-37.65%28.91M-59.57%172.13M-38.16%39.23M-88.84%33.14M76.00%53.39M32.66%46.37M
Net issuance payments of debt --0------------------0----------------
Proceeds from stock option exercised by employees 105.44%302.95M17.43%36.28M335.54%108.04M168.81%132.78M-38.97%25.86M-43.14%147.46M-45.53%30.89M-83.79%24.81M119.50%49.39M56.22%42.37M
Net other financing activities -135.64%-8.79M-163.37%-5.28M-163.37%-5.28M-132.05%-1.28M-23.70%3.05M128.16%24.67M107.50%8.33M6.38%8.33M-48.94%4M-48.93%4M
Cash from discontinued financing activities
Financing cash flow 70.89%294.16M-20.98%31M210.08%102.76M146.27%131.5M-37.65%28.91M-59.57%172.13M-38.16%39.23M-88.84%33.14M76.00%53.39M32.66%46.37M
Net cash flow
Beginning cash position -6.18%814.88M6.50%1.1B47.16%971.19M1.53%684.72M-6.18%814.88M5.64%868.56M-3.74%1.04B14.24%659.98M25.76%674.41M5.64%868.56M
Current changes in cash 381.38%169.01M49.58%-116.58M-69.56%116.21M2,124.43%289.59M38.76%-120.22M-211.57%-60.06M-10.92%-231.22M-22.97%381.79M-128.43%-14.31M30.79%-196.32M
Effect of exchange rate changes -338.44%-15.24M-258.49%-17.27M330.36%15.09M-2,300.00%-3.12M-556.85%-9.94M186.02%6.39M573.07%10.9M-423.72%-6.55M98.53%-130K197.23%2.18M
End cash Position 18.87%968.65M18.87%968.65M6.50%1.1B47.16%971.19M1.53%684.72M-6.18%814.88M-6.18%814.88M-3.74%1.04B14.24%659.98M25.76%674.41M
Free cash flow -201.54%-42.59M-130.04%-103.76M-88.46%39.52M255.05%116.14M47.61%-94.49M106.84%41.95M70.64%-45.1M359.74%342.32M46.06%-74.91M4.59%-180.37M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Bit Origin
BTOG
+6.57%
Bakkt Holdings
BKKT
+3.45%
The9 Ltd
NCTY
+1.32%
Abits
ABTS
+0.05%
Intchains Group
ICG
0.00%

Unlock the Full List